On 2025-05-13, Monopar Therapeutics Inc. (MNPR) announced earnings per share of $-0.38 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.65.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-0.47 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.65 | $-0.38 |
| 2025-03-31 | 2024-12-31 | $-0.36 | $-2.23 |
| 2024-11-08 | 2024-09-30 | $-0.46 | $-0.37 |
| 2024-08-09 | 2024-06-30 | $-0.45 | $-0.50 |
| 2024-05-09 | 2024-03-31 | $-0.85 | $-0.50 |
| 2024-03-28 | 2023-12-31 | $-0.85 | $-0.60 |
| 2023-11-09 | 2023-09-30 | $-0.95 | $-0.70 |
| 2023-08-10 | 2023-06-30 | $-0.95 | $-0.80 |
| 2023-05-11 | 2023-03-31 | $-1.00 | $-0.95 |
| 2023-03-23 | 2022-12-31 | $-1.05 | $-1.10 |
| 2022-11-10 | 2022-09-30 | $-1.15 | $-0.95 |
| 2022-08-11 | 2022-06-30 | $-1.05 | $-1.10 |
| 2022-05-12 | 2022-03-31 | $-1.20 | $-0.95 |
| 2022-03-24 | 2021-12-31 | $-0.90 | $-1.05 |
| 2021-11-12 | 2021-09-30 | $-1.10 | $-1.00 |
| 2021-08-12 | 2021-06-30 | $-1.05 | $-0.85 |
| 2021-05-13 | 2021-03-31 | $-1.10 | $-0.80 |
| 2021-03-25 | 2020-12-31 | $-0.75 | $-0.95 |
| 2020-11-12 | 2020-09-30 | $-0.75 | $-1.35 |
| 2020-08-06 | 2020-06-30 | $-1.25 | $-0.70 |
| 2020-05-07 | 2020-03-31 | -- | $-0.50 |
| 2020-03-27 | 2019-12-31 | $-0.35 | $-0.65 |